ACE inhibitor potentiation of bradykinin-induced venoconstriction. - Wikidata - wikimedia - TriplyDB

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

http://www.wikidata.org/entity/Q41915142

about

Kinins, receptors, kininases and inhibitors--where did they lead us?Inhibition of kinin breakdown prolongs retention and action of bradykinin in a myocardial B2 receptor compartment.Cellular targets for angiotensin II fragments: pharmacological and molecular evidence.The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs.The role of the renal kallikrein-kinin system in diabetic nephropathy.Gadolinium chloride modulates bradykinin-induced pulmonary vasoconstriction and hypoxic pulmonary vasoconstriction during polymicrobial abdominal sepsis in rats.Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins.Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.Are multiple angiotensin receptor types involved in angiotensin (1-7) actions on isolated rat portal vein.

P2860

Q34189945-4B115EE7-10E3-4A6D-A120-A537D8095994 Q35044915-E3505DB0-11C0-4CAC-A36F-8408FC3233BD Q35065512-FD7F9459-F6E2-46C6-8B1D-1A691172AF54 Q35148421-736F1C63-F409-4226-B417-AE31778FB2FE Q36013124-9D56796A-0C6F-475F-A8CC-F35D681E2C83 Q36210919-953BF755-9625-42B7-AA38-91222FD94D26 Q36513478-B2F1E7DA-91B2-4A67-ADDB-54451A4F369F Q38998211-E21494F5-8090-4E60-A1CB-20D5DF62DB7B Q43811771-EE6A88D3-4323-404E-A472-C43EEBF5AAB9 Q43948121-BE057D41-6EAF-4B46-B935-CE4F18E64253 Q46937797-460C0244-30EE-47A2-B310-AD37F7AF3141

P2860

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

http://www.wikidata.org/entity/Q41915142

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

@en

type

label

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

@en

prefLabel

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

@en

P1433

Q41915142-8FCB2B40-F950-4920-AEFC-996CFE758F76

P1476

Q41915142-1C3C1FBC-C67A-4FB8-9FD2-CABD2049E356

P2093

Q41915142-1CDC3151-35EE-4B4D-BE00-71B68AE1906E

Q41915142-79061290-F049-4BB6-A7E8-A37E1A9DD437

Q41915142-9D969CB6-EAE5-487F-A8D8-088A74F343D1

Q41915142-E3E6EBF4-78F9-4AB6-8F6D-3032BA6B35C3

P2860

Q41915142-259DB287-F9CE-4196-9A22-7C9C85701596

Q41915142-5025187A-FBBB-4C6C-83A5-8B50A2C5CE64

Q41915142-6DDD8BC4-164B-4CF1-9C6D-3EC3BC1EA208

Q41915142-6F8108F6-0F9B-4BA4-8362-DD63F3225C96

Q41915142-7A9CB39D-073C-40FD-B559-D8156E3287A7

Q41915142-7AD0CDF6-40E7-4C9D-80AE-6F91A8E8206C

Q41915142-A9C634BC-EEC1-401A-9B73-FC135D371E19

Q41915142-B8B35E4D-4288-4469-B185-BBF1B3BDE11C

P304

Q41915142-E897446B-E121-4A2A-960E-3D2C710D5D75

P31

Q41915142-98196E79-ED56-42AD-8C7E-A123F53C865B

P356

Q41915142-084C1B4C-3A5F-4199-8F96-8CAE36E08F02

P407

Q41915142-CE1F9083-5F6F-4C68-BDED-13BB590C94BC

P433

Q41915142-242DDABE-FA27-4983-A8BE-D8CDDCEFFEF2

P478

Q41915142-AF9AFA5D-8154-44B3-A701-A230C5085413

P50

Q41915142-714FCE6D-FD8A-4402-82FA-6990F765F8FD

P577

Q41915142-9DEDA8ED-E86E-4061-823C-B6BB3049CCB1

P5875

Q41915142-5D44041E-4977-4150-BD47-A14A07A7BD0A

P698

Q41915142-1CE19AF5-25B8-4B2A-B808-DF7953606FCA

P932

Q41915142-087FA89D-AC48-49B1-BA1F-3B808E4650AF

P356

P1433

British Journal of Pharmacology

P1476

ACE inhibitor potentiation of bradykinin-induced venoconstriction.

@en

P2093

Bara AT

http://www.w3.org/2001/XMLSchema#string

Blaukat A

http://www.w3.org/2001/XMLSchema#string

Busse R

http://www.w3.org/2001/XMLSchema#string

Hecker M

http://www.w3.org/2001/XMLSchema#string

P2860

Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.

Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.

Molecular responses of endothelial tissue to kinins.

Potentiation by aminopeptidase P of blood pressure response to bradykinin.

Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications.

Characterization of vascular relaxant factor released from cultured endothelial cells.

Endothelium-mediated vasodilation during ACE inhibition.

Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.

P304

1475-1481

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0701281

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Werner Müller-Esterl

P577

1997-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13962152

http://www.w3.org/2001/XMLSchema#string

P698

9257930

http://www.w3.org/2001/XMLSchema#string

P932

1564840

http://www.w3.org/2001/XMLSchema#string